The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Anti Microbial Peptides-Global Market Insights and Sales Trends 2024
Synopsis
Antimicrobial peptides (AMPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
The global Anti Microbial Peptides market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Anti Microbial Peptides in various end use industries. The expanding demands from the Personal Care and Cosmetics, Healthcare & Pharmaceuticals and Biotechnology,, are propelling Anti Microbial Peptides market. Plant Anti-Microbial Peptides, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bacterial Anti-Microbial Peptides segment is estimated at % CAGR for the next seven-year period.
Global anti-microbial peptides market is segmented on the basis of peptides types such as plant anti-microbial peptides, bacterial anti-microbial peptides, animal anti-microbial peptides, insect anti-microbial peptides. Among these segments, animal and plant anti-microbial peptides are capturing the major share into the market as they are easy to extract as compared with other anti-microbial peptides. Researchers are also more inclined towards animal and plant anti-microbial peptides to observe and check under clinical trials.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anti Microbial Peptides, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anti Microbial Peptides market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anti Microbial Peptides market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anti Microbial Peptides sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anti Microbial Peptides covered in this report include AnaSpec, Novozymes, Bachem, Phoenix Biotech, AMP Biotech, Shanghai Abbiochem Company, Ramamoorthy Group, Lytix Biopharma and Ai2, etc.
The global Anti Microbial Peptides market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AnaSpec
Novozymes
Bachem
Phoenix Biotech
AMP Biotech
Shanghai Abbiochem Company
Ramamoorthy Group
Lytix Biopharma
Ai2
Global Anti Microbial Peptides market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anti Microbial Peptides market, Segment by Type:
Plant Anti-Microbial Peptides
Bacterial Anti-Microbial Peptides
Animal Anti-Microbial Peptides
Insects Anti-Microbial Peptides
Global Anti Microbial Peptides market, by Application
Personal Care and Cosmetics
Healthcare & Pharmaceuticals
Biotechnology
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Anti Microbial Peptides manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Anti Microbial Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Antimicrobial peptides (AMPs) are part of the innate immune response found among all classes of life. Fundamental differences exist between prokaryotic and eukaryotic cells that may represent targets for antimicrobial peptides. These peptides are potent, broad spectrum antibiotics which demonstrate potential as novel therapeutic agents. Antimicrobial peptides have been demonstrated to kill Gram negative and Gram positive bacteria, enveloped viruses, fungi and even transformed or cancerous cells. Unlike the majority of conventional antibiotics it appears that antimicrobial peptides frequently destabilize biological membranes, can form transmembrane channels, and may also have the ability to enhance immunity by functioning as immunomodulators.
The global Anti Microbial Peptides market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Anti Microbial Peptides in various end use industries. The expanding demands from the Personal Care and Cosmetics, Healthcare & Pharmaceuticals and Biotechnology,, are propelling Anti Microbial Peptides market. Plant Anti-Microbial Peptides, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Bacterial Anti-Microbial Peptides segment is estimated at % CAGR for the next seven-year period.
Global anti-microbial peptides market is segmented on the basis of peptides types such as plant anti-microbial peptides, bacterial anti-microbial peptides, animal anti-microbial peptides, insect anti-microbial peptides. Among these segments, animal and plant anti-microbial peptides are capturing the major share into the market as they are easy to extract as compared with other anti-microbial peptides. Researchers are also more inclined towards animal and plant anti-microbial peptides to observe and check under clinical trials.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Anti Microbial Peptides, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Anti Microbial Peptides market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Anti Microbial Peptides market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Anti Microbial Peptides sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Anti Microbial Peptides covered in this report include AnaSpec, Novozymes, Bachem, Phoenix Biotech, AMP Biotech, Shanghai Abbiochem Company, Ramamoorthy Group, Lytix Biopharma and Ai2, etc.
The global Anti Microbial Peptides market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
AnaSpec
Novozymes
Bachem
Phoenix Biotech
AMP Biotech
Shanghai Abbiochem Company
Ramamoorthy Group
Lytix Biopharma
Ai2
Global Anti Microbial Peptides market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Anti Microbial Peptides market, Segment by Type:
Plant Anti-Microbial Peptides
Bacterial Anti-Microbial Peptides
Animal Anti-Microbial Peptides
Insects Anti-Microbial Peptides
Global Anti Microbial Peptides market, by Application
Personal Care and Cosmetics
Healthcare & Pharmaceuticals
Biotechnology
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Anti Microbial Peptides manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Anti Microbial Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Anti Microbial Peptides Market Overview
1.1 Anti Microbial Peptides Product Overview
1.2 Anti Microbial Peptides Market Segment by Type
1.2.1 Plant Anti-Microbial Peptides
1.2.2 Bacterial Anti-Microbial Peptides
1.2.3 Animal Anti-Microbial Peptides
1.2.4 Insects Anti-Microbial Peptides
1.3 Global Anti Microbial Peptides Market Size by Type
1.3.1 Global Anti Microbial Peptides Market Size Overview by Type (2018-2029)
1.3.2 Global Anti Microbial Peptides Historic Market Size Review by Type (2018-2023)
1.3.3 Global Anti Microbial Peptides Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anti Microbial Peptides Sales Breakdown by Type (2018-2023)
1.4.2 Europe Anti Microbial Peptides Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Anti Microbial Peptides Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Anti Microbial Peptides Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Anti Microbial Peptides Sales Breakdown by Type (2018-2023)
2 Global Anti Microbial Peptides Market Competition by Company
2.1 Global Top Players by Anti Microbial Peptides Sales (2018-2023)
2.2 Global Top Players by Anti Microbial Peptides Revenue (2018-2023)
2.3 Global Top Players by Anti Microbial Peptides Price (2018-2023)
2.4 Global Top Manufacturers Anti Microbial Peptides Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anti Microbial Peptides Market Competitive Situation and Trends
2.5.1 Anti Microbial Peptides Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Anti Microbial Peptides Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anti Microbial Peptides as of 2022)
2.7 Date of Key Manufacturers Enter into Anti Microbial Peptides Market
2.8 Key Manufacturers Anti Microbial Peptides Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anti Microbial Peptides Status and Outlook by Region
3.1 Global Anti Microbial Peptides Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Anti Microbial Peptides Historic Market Size by Region
3.2.1 Global Anti Microbial Peptides Sales in Volume by Region (2018-2023)
3.2.2 Global Anti Microbial Peptides Sales in Value by Region (2018-2023)
3.2.3 Global Anti Microbial Peptides Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Anti Microbial Peptides Forecasted Market Size by Region
3.3.1 Global Anti Microbial Peptides Sales in Volume by Region (2024-2029)
3.3.2 Global Anti Microbial Peptides Sales in Value by Region (2024-2029)
3.3.3 Global Anti Microbial Peptides Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Anti Microbial Peptides by Application
4.1 Anti Microbial Peptides Market Segment by Application
4.1.1 Personal Care and Cosmetics
4.1.2 Healthcare & Pharmaceuticals
4.1.3 Biotechnology
4.2 Global Anti Microbial Peptides Market Size by Application
4.2.1 Global Anti Microbial Peptides Market Size Overview by Application (2018-2029)
4.2.2 Global Anti Microbial Peptides Historic Market Size Review by Application (2018-2023)
4.2.3 Global Anti Microbial Peptides Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anti Microbial Peptides Sales Breakdown by Application (2018-2023)
4.3.2 Europe Anti Microbial Peptides Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Anti Microbial Peptides Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Anti Microbial Peptides Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Anti Microbial Peptides Sales Breakdown by Application (2018-2023)
5 North America Anti Microbial Peptides by Country
5.1 North America Anti Microbial Peptides Historic Market Size by Country
5.1.1 North America Anti Microbial Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Anti Microbial Peptides Sales in Volume by Country (2018-2023)
5.1.3 North America Anti Microbial Peptides Sales in Value by Country (2018-2023)
5.2 North America Anti Microbial Peptides Forecasted Market Size by Country
5.2.1 North America Anti Microbial Peptides Sales in Volume by Country (2024-2029)
5.2.2 North America Anti Microbial Peptides Sales in Value by Country (2024-2029)
6 Europe Anti Microbial Peptides by Country
6.1 Europe Anti Microbial Peptides Historic Market Size by Country
6.1.1 Europe Anti Microbial Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Anti Microbial Peptides Sales in Volume by Country (2018-2023)
6.1.3 Europe Anti Microbial Peptides Sales in Value by Country (2018-2023)
6.2 Europe Anti Microbial Peptides Forecasted Market Size by Country
6.2.1 Europe Anti Microbial Peptides Sales in Volume by Country (2024-2029)
6.2.2 Europe Anti Microbial Peptides Sales in Value by Country (2024-2029)
7 Asia-Pacific Anti Microbial Peptides by Region
7.1 Asia-Pacific Anti Microbial Peptides Historic Market Size by Region
7.1.1 Asia-Pacific Anti Microbial Peptides Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Anti Microbial Peptides Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Anti Microbial Peptides Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Anti Microbial Peptides Forecasted Market Size by Region
7.2.1 Asia-Pacific Anti Microbial Peptides Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Anti Microbial Peptides Sales in Value by Region (2024-2029)
8 Latin America Anti Microbial Peptides by Country
8.1 Latin America Anti Microbial Peptides Historic Market Size by Country
8.1.1 Latin America Anti Microbial Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Anti Microbial Peptides Sales in Volume by Country (2018-2023)
8.1.3 Latin America Anti Microbial Peptides Sales in Value by Country (2018-2023)
8.2 Latin America Anti Microbial Peptides Forecasted Market Size by Country
8.2.1 Latin America Anti Microbial Peptides Sales in Volume by Country (2024-2029)
8.2.2 Latin America Anti Microbial Peptides Sales in Value by Country (2024-2029)
9 Middle East and Africa Anti Microbial Peptides by Country
9.1 Middle East and Africa Anti Microbial Peptides Historic Market Size by Country
9.1.1 Middle East and Africa Anti Microbial Peptides Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Anti Microbial Peptides Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Anti Microbial Peptides Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Anti Microbial Peptides Forecasted Market Size by Country
9.2.1 Middle East and Africa Anti Microbial Peptides Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Anti Microbial Peptides Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 AnaSpec
10.1.1 AnaSpec Company Information
10.1.2 AnaSpec Introduction and Business Overview
10.1.3 AnaSpec Anti Microbial Peptides Sales, Revenue and Gross Margin (2018-2023)
10.1.4 AnaSpec Anti Microbial Peptides Products Offered
10.1.5 AnaSpec Recent Development
10.2 Novozymes
10.2.1 Novozymes Company Information
10.2.2 Novozymes Introduction and Business Overview
10.2.3 Novozymes Anti Microbial Peptides Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Novozymes Anti Microbial Peptides Products Offered
10.2.5 Novozymes Recent Development
10.3 Bachem
10.3.1 Bachem Company Information
10.3.2 Bachem Introduction and Business Overview
10.3.3 Bachem Anti Microbial Peptides Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Bachem Anti Microbial Peptides Products Offered
10.3.5 Bachem Recent Development
10.4 Phoenix Biotech
10.4.1 Phoenix Biotech Company Information
10.4.2 Phoenix Biotech Introduction and Business Overview
10.4.3 Phoenix Biotech Anti Microbial Peptides Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Phoenix Biotech Anti Microbial Peptides Products Offered
10.4.5 Phoenix Biotech Recent Development
10.5 AMP Biotech
10.5.1 AMP Biotech Company Information
10.5.2 AMP Biotech Introduction and Business Overview
10.5.3 AMP Biotech Anti Microbial Peptides Sales, Revenue and Gross Margin (2018-2023)
10.5.4 AMP Biotech Anti Microbial Peptides Products Offered
10.5.5 AMP Biotech Recent Development
10.6 Shanghai Abbiochem Company
10.6.1 Shanghai Abbiochem Company Company Information
10.6.2 Shanghai Abbiochem Company Introduction and Business Overview
10.6.3 Shanghai Abbiochem Company Anti Microbial Peptides Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Shanghai Abbiochem Company Anti Microbial Peptides Products Offered
10.6.5 Shanghai Abbiochem Company Recent Development
10.7 Ramamoorthy Group
10.7.1 Ramamoorthy Group Company Information
10.7.2 Ramamoorthy Group Introduction and Business Overview
10.7.3 Ramamoorthy Group Anti Microbial Peptides Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Ramamoorthy Group Anti Microbial Peptides Products Offered
10.7.5 Ramamoorthy Group Recent Development
10.8 Lytix Biopharma
10.8.1 Lytix Biopharma Company Information
10.8.2 Lytix Biopharma Introduction and Business Overview
10.8.3 Lytix Biopharma Anti Microbial Peptides Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Lytix Biopharma Anti Microbial Peptides Products Offered
10.8.5 Lytix Biopharma Recent Development
10.9 Ai2
10.9.1 Ai2 Company Information
10.9.2 Ai2 Introduction and Business Overview
10.9.3 Ai2 Anti Microbial Peptides Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Ai2 Anti Microbial Peptides Products Offered
10.9.5 Ai2 Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anti Microbial Peptides Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anti Microbial Peptides Industrial Chain Analysis
11.4 Anti Microbial Peptides Market Dynamics
11.4.1 Anti Microbial Peptides Industry Trends
11.4.2 Anti Microbial Peptides Market Drivers
11.4.3 Anti Microbial Peptides Market Challenges
11.4.4 Anti Microbial Peptides Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anti Microbial Peptides Distributors
12.3 Anti Microbial Peptides Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
